The 3NCP alleviates memory impairment, reduced plaque formation, and inhibits BACE-1 activity, displaying activities comparable or higher than the reported drugs such as melatonin, quercetin, and rutin [47,48,49]. This evidence concerns the gene BACE1 and memory impairment.